Breaking News

BeiGene Breaks Ground on NJ Manufacturing and Clinical R&D Center

Flagship U.S. facility will include biologic manufacturing and late-stage research and clinical development of cancer medicines.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Global biotech BeiGene broke ground on its flagship U.S. manufacturing and clinical R&D center at the Princeton West Innovation Campus in Hopewell, NJ. “Our planned flagship U.S. R&D and manufacturing center supports our commitment to fight for life for people living with cancer around the world, through state-of-the-art commercial-stage biologic pharmaceutical manufacturing, late-stage research and clinical development capabilities,” said John Oyler, CEO of BeiGene. “The Princeton-Ho...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters